{"id":61747,"date":"2025-08-19T22:05:30","date_gmt":"2025-08-19T20:05:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/"},"modified":"2025-08-19T22:05:30","modified_gmt":"2025-08-19T20:05:30","slug":"anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/","title":{"rendered":"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Anaergia anticipates C$184 million in revenue from the Agreement<\/i><\/p>\n<p>TREVIGLIO, Italy &amp; BURLINGTON, Ontario&#8211;(BUSINESS WIRE)&#8211;Anaergia Inc. (\u201cAnaergia\u201d, the \u201cCompany\u201d, \u201cus\u201d, or \u201cour\u201d) (TSX:ANRG; OTCQX:ANRGF), through its subsidiary Anaergia S.r.l., has signed a Binding Agreement (\u201cAgreement\u201d) with a leading Spanish company specializing in renewable gas infrastructure projects. Under the terms of the Agreement, Anaergia will provide a range of services as well as its cutting-edge technology and equipment for over 15 new biomethane production plants across Spain.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/5\/Anaergia_Logo_2021_w_Tag.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/5\/Anaergia_Logo_2021_w_Tag.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/21\/Anaergia_Logo_2021_w_Tag.jpg\"><\/a><\/p>\n<p>\nAnaergia will be responsible for the supply and construction of concrete tanks with Triton\u2122 digesters, a proprietary technology featuring a patented configuration that significantly enhances process efficiency. In addition, the company will supply advanced mixing systems, also part of its proprietary technology, along with other critical components to facilitate the seamless operations of the plants.<\/p>\n<p>\nAnaergia is to commence activities on the first project this month, with all the projects in the development plan expected to be fully operational and integrated into Spain\u2019s gas pipeline network within forty-eight months. Anaergia anticipates total revenue of C$184 million from this Agreement, making it the Company\u2019s largest capital sale to date.<\/p>\n<p>\n\u201cThis agreement marks a significant milestone in advancing Spain\u2019s renewable energy sector, fostering economic growth and environmental sustainability. The scale of this historic Agreement for Anaergia highlights the advantages of our strategic focus on leveraging proprietary technologies for the benefit of our customers, and underscores our growing presence and activities in Europe,\u201d said Assaf Onn, CEO of Anaergia. \u201cWe are most excited about this opportunity to demonstrate the value of our innovative solutions and to support the global transition to renewable energy.\u201d<\/p>\n<p>\n<b>About Anaergia<\/b><\/p>\n<p>\nAnaergia is a pioneering technology company in the renewable natural gas (RNG) sector, with over 250 patents dedicated to converting organic waste into sustainable solutions such as RNG, fertilizer, and water. We are committed to addressing a significant source of greenhouse gases (GHGs) through cost-effective processes. Our proprietary technologies, combined with our engineering expertise and vast experience in facility design, construction, and operation, position Anaergia as a leader in the RNG industry. With a proven track record of delivering hundreds of innovative projects over the past decade, we are well-equipped to tackle today\u2019s critical resource recovery challenges through diverse project delivery methods. As one of the few companies worldwide offering an integrated portfolio of end-to-end solutions, we effectively combine solid waste processing, wastewater treatment, organics recovery, high-efficiency anaerobic digestion, and biomethane production. Additionally, we operate RNG facilities owned by both third parties and Anaergia. This comprehensive approach not only reduces environmental impact but also significantly lowers costs associated with waste and wastewater treatment while mitigating GHG emissions.<\/p>\n<p>\nFor further information please see: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.anaergia.com&amp;esheet=54310363&amp;newsitemid=20250819914988&amp;lan=en-US&amp;anchor=www.anaergia.com&amp;index=1&amp;md5=d273012aa31cca794f9b0d8d27e6fbce\" rel=\"nofollow\" shape=\"rect\">www.anaergia.com<\/a><\/p>\n<p>\n<b>Forward-Looking Statements<\/b><\/p>\n<p>\n<i>This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects Anaergia\u2019s current expectations regarding future events, including but not limited to, counterparty contractual performance, the capability of the Company\u2019s technology and performance with respect to the project objectives. Forward-looking information is based on a number of assumptions, including, but not limited to counterparty contractual performance, the full development, timing and funding of construction of the sixteen facilities, the capability of the Company\u2019s technology and performance with respect to the project objectives, the expected revenue from the agreement, and the sufficient sourcing of food waste and power generation. The Company is subject to a number of risks and uncertainties, many of which are beyond the Company\u2019s control. Such risks and uncertainties include, but are not limited to, the factors discussed under \u201cRisk Factors\u201d in the Company\u2019s annual information form for the fiscal year ended December 31, 2024, and under \u201cRisks and Uncertainties\u201d in the Company\u2019s most recent management\u2019s discussion and analysis. Actual results could differ materially from those projected herein. Anaergia does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required under applicable securities laws. Additional information on these and other factors that could affect Anaergia\u2019s operations or financial results are included in Anaergia\u2019s reports on file with Canadian regulatory authorities.<\/i><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nFor media and\/or investor relations please contact: <a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#58;&#x49;&#x52;&#64;&#65;&#x6e;&#x61;e&#114;&#103;&#x69;&#x61;&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#73;R&#x40;A&#x6e;a&#x65;&#114;&#x67;&#105;&#x61;&#46;c&#x6f;m<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Anaergia anticipates C$184 million in revenue from the Agreement TREVIGLIO, Italy &amp; BURLINGTON, Ontario&#8211;(BUSINESS WIRE)&#8211;Anaergia Inc. (\u201cAnaergia\u201d, the \u201cCompany\u201d, \u201cus\u201d, or \u201cour\u201d) (TSX:ANRG; OTCQX:ANRGF), through its subsidiary Anaergia S.r.l., has signed a Binding Agreement (\u201cAgreement\u201d) with a leading Spanish company specializing in renewable gas infrastructure projects. Under the terms of the Agreement, Anaergia will provide &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61747","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Anaergia anticipates C$184 million in revenue from the Agreement TREVIGLIO, Italy &amp; BURLINGTON, Ontario&#8211;(BUSINESS WIRE)&#8211;Anaergia Inc. (\u201cAnaergia\u201d, the \u201cCompany\u201d, \u201cus\u201d, or \u201cour\u201d) (TSX:ANRG; OTCQX:ANRGF), through its subsidiary Anaergia S.r.l., has signed a Binding Agreement (\u201cAgreement\u201d) with a leading Spanish company specializing in renewable gas infrastructure projects. Under the terms of the Agreement, Anaergia will provide ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T20:05:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain\",\"datePublished\":\"2025-08-19T20:05:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/\"},\"wordCount\":719,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250819914988\\\/en\\\/1142102\\\/22\\\/Anaergia_Logo_2021_w_Tag.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/\",\"name\":\"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250819914988\\\/en\\\/1142102\\\/22\\\/Anaergia_Logo_2021_w_Tag.jpg\",\"datePublished\":\"2025-08-19T20:05:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250819914988\\\/en\\\/1142102\\\/22\\\/Anaergia_Logo_2021_w_Tag.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250819914988\\\/en\\\/1142102\\\/22\\\/Anaergia_Logo_2021_w_Tag.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/","og_locale":"en_US","og_type":"article","og_title":"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain - Pharma Trend","og_description":"Anaergia anticipates C$184 million in revenue from the Agreement TREVIGLIO, Italy &amp; BURLINGTON, Ontario&#8211;(BUSINESS WIRE)&#8211;Anaergia Inc. (\u201cAnaergia\u201d, the \u201cCompany\u201d, \u201cus\u201d, or \u201cour\u201d) (TSX:ANRG; OTCQX:ANRGF), through its subsidiary Anaergia S.r.l., has signed a Binding Agreement (\u201cAgreement\u201d) with a leading Spanish company specializing in renewable gas infrastructure projects. Under the terms of the Agreement, Anaergia will provide ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-19T20:05:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain","datePublished":"2025-08-19T20:05:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/"},"wordCount":719,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/","url":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/","name":"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg","datePublished":"2025-08-19T20:05:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250819914988\/en\/1142102\/22\/Anaergia_Logo_2021_w_Tag.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/anaergia-s-r-l-announces-agreement-to-provide-infrastructure-and-equipment-for-new-biomethane-plants-in-spain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anaergia S.r.l. Announces Agreement to Provide Infrastructure and Equipment for New Biomethane Plants in Spain"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61747"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61747\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}